Ginkgo Bioworks Stock Has 37.5% Downside, According to 1 Wall Street Analyst

Ginkgo Bioworks has become a penny stock -- and that's the least of its problems,

Related Keywords

Mark Massaro ,Nvidia ,Ginkgo Bioworks ,Motley Fool Stock Advisor ,Stock Advisorservice ,